Wild, C. (2005): [Treatment of osteoporosis]. HTA-Newsletter 41: pp. 3-4.
Preview |
PDF (HTA-Newsletter 41)
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
112kB |
Official URL: http://hw.oeaw.ac.at/ita/hta-newsletter?frames=yes
Item Type: | HTA Newsletter Item |
---|---|
Keywords: | Postmenopausal osteoporosis, risk of fracture, drug therapy, alendronate, etidronate, risedronate, raloxifene, teriparatide, effectiveness |
Subjects: | WE Musculoskeletal system > WE 200-259 Bones WB Practice of medicine > WB 340-356 Drug Administration |
Related URLs: | |
References: | 1. NCCHTA/GB 2005: A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. URL: http://www.ncchta.org/execsumm/summ922.htm. 2. CCOHTA/Ca 2003: Treating osteoporosis with teriparatide: many unknowns? URL: http://www.ccohta.ca. |
Language: | German |
Number: | 41 |
Deposited on: | 06 Mar 2008 14:19 |
Last Modified: | 15 Jul 2020 17:37 |
Repository Staff Only: item control page